SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Backman C. Employment and work disability in rheumatoid arthritis. Curr Opin Rheumatol 2004; 16: 14852.
  • 2
    Fex E, Larsson B, Nived K, Eberhardt K. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 1998; 25: 4450.
  • 3
    Mau W, Bornmann M, Weber H, Weidemann H. Deficiencies in rehabilitation measures in the course of early chronic polyarthritis. J Rheumatol 1996; 55: 2239.
  • 4
    Li X, Gignac M, Anis A. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care 2006; 44: 30410.
  • 5
    Lacaille D. Arthritis and employment research: where are we? Where do we need to go? J Rheumatol Suppl 2005; 72: 425.
  • 6
    Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, Strand V, et al. Worker productivity outcome measures in arthritis. J Rheumatol 2007; 34: 137280.
  • 7
    Wolfe F, Allaire S, Michaud K. The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol 2007; 34: 17.
  • 8
    Allaire S. Update on work disability in rheumatic diseases. Curr Opin Rheumatol 2001; 13: 938.
  • 9
    Hammond A, Young A, Kidao R. A randomized controlled trial of occupational therapy for people with early rheumatoid arthritis. Ann Rheum Dis 2004; 63: 2330.
  • 10
    Gilworth G, Chamberlain M, Harvey A, Woodhouse A, Smith J, Smyth M, et al. Development of a work instability scale for rheumatoid arthritis. Arthritis Rheum 2003; 49: 34954.
  • 11
    Law M, Baptiste S, Carswell S, McColl M, Polatajko H, Pollock N. Canadian occupational performance measure. 3rd ed. Ottawa: CAOT; 1998.
  • 12
    Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Hakala M, Korpela M, et al. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann Rheum Dis 2005; 64: 1303.
  • 13
    Smolen J, Han C, van der Heijde, Emery P, Bathon JM, Keystone E, et al. Infliximab treatment maintains employability in patients with early rheumatoid arthritis. Arthritis Rheum 2006; 54: 71622.
  • 14
    Canadian Association of Occupational Therapists. Enabling occupation: an occupational therapy perspective. Ottawa: CAOT; 1997.
  • 15
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 16
    Allaire S. Measures of adult work disability: the Work Limitations Questionnaire (WLQ) and the Rheumatoid Arthritis Work Instability Scale (RA-WIS). Arthritis Rheum 2003; 49 Suppl: S859.
  • 17
    Fries J, Spitz P, Kraines R, Holman H. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 18
    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005; 52: 3389.
  • 19
    Meenan R, Mason J, Anderson J, Guccione A, Kazis L. AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 1992; 35: 110.
  • 20
    Stein M, Wallston K, Nicassio P. Factor structure of the Arthritis Helplessness Index. J Rheumatol 1988; 15: 42732.
  • 21
    The EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199208.
  • 22
    Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 448.
  • 23
    Gardiner P, Bell A, Taggart A, Wright G, Kee F, Smyth A, et al. A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis [letter]. Ann Rheum Dis 2005; 64: 5067.
  • 24
    Balsa A, Carmona L, Gonzalez-Alvaro I, Belmonte M, Tena X, Sanmarti R. Value of Disease Activity Score 28 (DAS28) and DAS28–3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol 2004; 31: 406.
  • 25
    Fransen J, Creemers M, van Riel P. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004; 43: 12525.
  • 26
    Van Gestel A, Prevoo M, van 't Hof M, van Rijswijk M, van de Putte L, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 3440.
  • 27
    Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Hakala M, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005; 52: 3641.
  • 28
    Lacaille D. Arthritis and employment research: where are we? Where do we need to go? [review]. J Rheumatol Suppl 2005; 72: 425.
  • 29
    Sokka T, Verstappen S, Hetland M, Makinen H, Naranjo A, Belmonte M, et al. Work disability in patients with rheumatoid arthritis in 15 countries [abstract]. Arthritis Rheum 2006; 54 Suppl: S99.
  • 30
    Kvien T, Heiberg T. Patient perspective in outcome assessments: perceptions or something more? J Rheumatol 2003; 30: 8736.
  • 31
    Burton W, Chen C, Schultz A, Conti D, Pransky G, Edington D. Worker productivity loss associated with arthritis. Dis Manag 2006; 9: 13143.
  • 32
    Allaire S, Li W, LaValley M. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation: a randomized controlled trial. Arthritis Rheum 2003; 48: 32128.
  • 33
    Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Julkunen H, et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum 2004; 50: 5562.